<DOC>
	<DOCNO>NCT02080299</DOCNO>
	<brief_summary>Transcatheter aortic valve implantation ( TAVI ) rapidly adopt clinical practice , concern raise regard periprocedural complication like e.g . myocardial injury , stroke acute kidney injury . Remote ischemic preconditioning ( RIPC ) upper limb ischemia/reperfusion provide perioperative myocardial protection patient undergo elective coronary artery bypass surgery . The present study assess protection heart , brain kidney RIPC patient undergo TAVI . The study also address safety clinical outcome .</brief_summary>
	<brief_title>Protection Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation</brief_title>
	<detailed_description>- On assumption recent data ( Thielmann et al , Lancet 2013 , 382 ( 9892 ) :597-604 ) , perform power analysis , reveal estimate enrollment 189 patient per group . But since true data exist regard RIPC TAVI , interim analysis perform 50 patient per group . - After induction conscious sedation general anaesthesia , RIPC accomplish 3 cycle 5 min inflation/5 min deflation blood pressure cuff around leave arm 200 mm Hg . In placebo group , blood pressure cuff remain uninflated 30 min . - Blind : study coordinator , outcome assessor , operator treat physician except attend anaesthetist . - Drugs use conscious sedation : midazolam , remifentanil . - Drugs use general anaesthesia : sufentanil , etomidate , rocuronium , isoflurane . - TAVI perform standard technique use balloon-expandable Sapien XT ( Edwards Lifesciences Inc. , Irvine , California , USA ) next-generation Sapien 3 stent-valve bioprosthesis replaces Sapien XT prosthesis , CE-approved . - Arterial blood sample obtain prior RIPC-maneuver/Placebo , aortic valve implantation access site closure , biochemical analysis focus ligands previously implicate conditioning protocol various organ . A bioassay system , consist Langendorff-perfused isolated heart ischemia reperfusion use . This bioassay system expose obtain arterial plasma patient . - Venous blood sample draw TAVI 1 , 6 , 12 , 24 , 48 72 hour procedure . - Cardiac cerebral MRI perform select patient baseline within first week TAVI . - On-site follow-up 3±3 month , 12±3 month yearly thereafter .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Adult patient severe symptomatic native aortic valve stenosis schedule elective TAVI due prohibitive high risk surgical aortic valve replacement judge institutional heart team base risk score comorbidity assessment Written inform consent Life expectancy &lt; 1 year Patients unlikely gain improvement quality life TAVI procedure Unfavorable anatomy TAVI ( e.g . inadequate annulus size ) Leftventricular thrombus Active endocarditis Active infection Acute STsegment elevation myocardial infarction Hemodynamic instability Preoperative troponin I concentration upper normal limit 0.1 ng/ml Stroke within last 6 week Acute chronic hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>